Suppr超能文献

磷酸肌醇 3-激酶β和δ同工型在前列腺癌细胞 DU145 的转移中起关键作用。

Phosphatidylinositol 3-kinase β and δ isoforms play key roles in metastasis of prostate cancer DU145 cells.

机构信息

Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmaceutical Sciences, Tianjin Medical University, Tianjin, China.

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China.

出版信息

FASEB J. 2018 Nov;32(11):5967-5975. doi: 10.1096/fj.201800183R. Epub 2018 May 24.

Abstract

Metastasis is the main cause of the lethality of prostate cancer. Class I phosphatidylinositol 3-kinases (PI3Ks), which contain 4 isoforms, α, β, δ, and γ, are known to play important roles in cell growth, migration, invasion, and so on. However, the respective role of each PI3K isoform in cancer cell migration and invasion remains unknown. In a study that aimed to elucidate the respective role of the 4 PI3K isoforms, we investigated the change in migratory and invasive ability of DU145 cells after treatment with each PI3K isoform-specific inhibitor. Both migration and invasion of DU145 cells were potently blocked by each of the PI3Kβ inhibitors (GSK2636771 and TGX221) and PI3Kδ inhibitors (CAL101 and IC87114) while not obviously affected by PI3Kα inhibitor BYL719 or PI3Kγ inhibitor AS252424. Furthermore, knocking down PI3Kβ or PI3Kδ isoform led to a significant decrease in migration of DU145. The results suggest that PI3Kβ and PI3Kδ play key roles in prostate cancer cell migration, while PI3Kα and PI3Kγ might be redundant. Oral administration of GSK2636771 (100 mg/kg) and CAL101 (30 mg/kg) inhibited tumor growth in bone, an experimental model by intratibia injection of DU145 cells, with improved bone structure and bone mineral density analyzed by micro-computed tomography. Tissue staining indicated reduction of metastatic DU145 cells and osteoclasts in the bones of GSK2636771- and CAL101-treated mice compared to the untreated group. In summary, our results indicated the distinct roles of 4 PI3K isoforms in the migration of prostate cancer DU145 cells, and they demonstrated the in vitro and in vivo antimetastatic effect of PI3K-isoform specific inhibitors, most of which are in clinical trials.-Zhang, Z., Liu, J., Wang, Y., Tan, X., Zhao, W., Xing, X., Qiu, Y., Wang, R., Jin, M., Fan, G., Zhang, P., Zhong, Y., Kong, D. Phosphatidylinositol 3-kinase β and δ isoforms play key roles in metastasis of prostate cancer DU145 cells.

摘要

转移是前列腺癌致死的主要原因。已知包含 4 种同工型的 I 类磷脂酰肌醇 3-激酶(PI3Ks)在细胞生长、迁移、侵袭等方面发挥重要作用。然而,每种 PI3K 同工型在癌细胞迁移和侵袭中的作用尚不清楚。在一项旨在阐明 4 种 PI3K 同工型各自作用的研究中,我们研究了用每种 PI3K 同工型特异性抑制剂处理后 DU145 细胞迁移和侵袭能力的变化。PI3Kβ 抑制剂(GSK2636771 和 TGX221)和 PI3Kδ 抑制剂(CAL101 和 IC87114)均能强烈抑制 DU145 细胞的迁移和侵袭,而 PI3Kα 抑制剂 BYL719 或 PI3Kγ 抑制剂 AS252424 则无明显影响。此外,敲低 PI3Kβ 或 PI3Kδ 同工型会导致 DU145 细胞迁移显著减少。结果表明,PI3Kβ 和 PI3Kδ 在前列腺癌细胞迁移中起关键作用,而 PI3Kα 和 PI3Kγ 可能是多余的。口服给予 GSK2636771(100mg/kg)和 CAL101(30mg/kg)可抑制 DU145 细胞经胫骨内注射入实验模型骨中的肿瘤生长,通过微计算机断层扫描分析改善骨结构和骨密度。组织染色表明,与未治疗组相比,GSK2636771 和 CAL101 治疗小鼠的骨骼中转移性 DU145 细胞和破骨细胞减少。综上所述,我们的结果表明 4 种 PI3K 同工型在前列腺癌 DU145 细胞迁移中具有不同的作用,并证明了 PI3K-同工型特异性抑制剂的体外和体内抗转移作用,其中大多数正在临床试验中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验